An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood Adv. 2022 04 12; 6(7):2035-2044.